Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Current ask: .04 (updated this AM)!
I’m not sure—perhaps ES can answer your questions. I was merely contesting the notion (suggested by another poster) that the candidate doctors drive this process with their eagerness. While eagerness is essential, CELZ will pick the best of the best.
They’ll be lining up to be CONSIDERED: Gershman, Ichim, Dickerson, et.al. will SELECT the docs who will have contracts.
“Throw shorty from the train!” CELZ
Bwahahaha!!!!
Happy to help in our collective effort!
Remember WOMEN’S urology potential!
How many times have you seen a headline on magazines in grocery checkout talking about women with “performance issues” of their own?
That number is, anecdotally, staggeringly high as well: PLEASE tell me that CELZ is hitting with BOTH barrels right out of the gate...
GTC SELL @ $5+ per share all shares.
THAT is “locked”!
Why not lock the ones you have NOW? Why make it easier for MMs to drive our PPS down?
Bingo! I am wired to pick things apart—always have been. No matter how I parse and analyze, I am unable to find anything that makes me doubt the legitimacy of this. I only wish that they were a little more forthcoming with things that they DO know now: the faster we get in some country and above, the harder it will be for dimwits to manipulate.
Name another OTC with internationally renowned experts as agents—who also have a track record taking stocks from pennies to dollars. That’s what we have in CELZ, hence our cautious but reasonable optimism.
Look! Dr. Gershman states, I’m pleased to take on this expanded role as a Manager of “CaverStem International”(👀 HINT). I have experienced first hand the safety and efficacy of the CaverStem procedure and I'm excited to introduce our technology! $CELZ @mdfacep@gershmanmdla
— Brian Ross (@brianross2112) June 24, 2018
Don’t like using drugs or shots in order to enhance your male performance?
— Elias Said, MD, FACEP (@MdFacep) June 24, 2018
Want an ALL NATURAL alternative?#CAVERSTEM™
✔️Scientifically proven
✔️Safe and Effective
✔️Non-invasive
✔️1 hour procedure
✔️Outpatient procedurehttps://t.co/Yv5lfkuijT #ErectileDysfunction https://t.co/FpncbuRbey
I understand the idea, but not the practical impact
Precisely—it’s called an “a fortiori” argument: to the extent that something was true of a company with MUCH less in terms of patents and that was NOWHERE near monetization, how much MORE would it be true of a company like CELZ?
Interesting. I infer from your comment (by extrapolation) that Dr. Gershman may likewise be doing this completely separately: why would the lower-level
docs be expected to but not the main doc himself?
Other related questions: (1) does splitting CaverStem off make it any more/less likely that they would entertain buyout? (2) what exactly will be the impact of the split-off on current shareholder equity? (3) does CaverStem international INCLUDE current US interests (would seem to make more sense—why would they bifurcate yet again by having TWO CaverStem entities?)?
When they do 100.000 CaverStem procedures, they will NET $120 million off the kits ALONE!
Where can I read something about exactly where AmnioStem is on the path to commercialization?
And Medistem was nowhere near monetization—CELZ is there NOW!
Derivative losses come DIRECTLY from the stock price going UP. They are NOT material losses.
https://en.m.wikipedia.org/wiki/Derivative_(finance)
Taking CaverStem international:
Dr. Gershman must clearly see significant financial benefits from being at the center of CaverStem International LLC—otherwise why would he sacrifice the time at the expense of his very lucrative practice in Beverly Hills? HE WOULDN’T.
Now let’s begin to ponder the comparative health and health care systems of some of the nations where CaverStem should be very popular.
https://nordic.businessinsider.com/the-16-countries-with-the-worlds-best-healthcare-systems-2017-1/
https://www.google.com/amp/s/www.forbes.com/sites/theapothecary/2015/01/27/conservative-think-tank-10-countries-with-universal-health-care-are-economically-freer-than-the-u-s/amp/
https://www.google.com/amp/s/www.nasdaq.com/article/all-the-countries-that-have-universal-healthcare-cm757323/amp
Imagine the appeal of CaverStem in “Mother Russia,” where diminished fertility must be an issue. Oh, and if the universal health insurance in Russia (and other nations) covers the procedure, LOOK OUT!
https://en.m.wikipedia.org/wiki/Healthcare_in_Russia ????
Where can I read from the company about the initiation of the specific clinical trials you allude to?
Did we have some clinical trial results released?
CaverStem web domains have been established for something like 35 cities. The doctors associated with these have exclusive contracts with the company. The company sells them the Magellan stem separator machine and few kits upon set-up.
My interpretation of the math reported in the last 10-Q reveals the following (about which I am 95% confident). We know that the CaverStem kits are sold to the doctors for $1,600 each, that $9,600 gross revenue was reported, and $7,200 net: 6 kits * $400 apiece (to produce) gives $2,400–the difference between the gross and net numbers.
It is also very likely that Dr. Gershman was responsible for the 6 procedures that I have inferred from the math because, as far as we know, only he was providing CaverStem during the quarter whose results were reported.
Fast forward to now: it is not unreasonable at all to imagine contracts and subsequent training for, let’s say, 25 doctors. Given how simple this procedure is (1-hour outpatient), we might expect doctors to take, say 5 kits at set-up.
25 doctors * 5 kits * $1,200 NET per kit= $150,000 net from kits alone
(This is a VERY conservative guess, and does not contain whatever margin CELZ probably makes on the Magellan). Even so, how do you think a jump from $7,200 net to $150,000 net will look quarter over quarter?
In addition, how likely do you think it is that Dr. Gershman would take significant time away from his VERY lucrative practice in Beverly Hills in order to involve himself deeply in the INTERNATIONAL commercialization of CaverStem—unless he imagined that he would make MORE doing this than working in his practice full time? NOT AT ALL.
Lastly, Dr. Gershman, Dr. Thomas Ichim, and CFO Donald Dickerson have already been down this road before with Medistem—which they took from under 5¢ a share and sold for $1.68 per share (at one time the stock had actually risen to $2.68/share before the buyout!). Medistem was NOWHERE near commercialization and monetization of their technology at that time: CELZ is there NOW!
Do your own DD (this board teems with folks doing this stuff all day!), but at the end, use critical thinking and common sense to behold this beautiful opportunity.
Longs on here + execs have, safely, ~200M of the ~650M OS LOCKED. Given basic laws of supply and demand, what effect do we expect when names, locations, and $ amounts for contracted physicians are officially released soon?
This is one of the biggest no-brainers EVER.
Gap alert! Current spread .0355-.0390 and rising...
ES: was what we witnessed on Thursday Bonaza 1, 2, or 3?
As of Thursday evening, I have contacted my own posse of hundreds from various personal and professional realms across the country, and invited them to learn more about CELZ.
Longs on here + execs have, safely, 200M of the ~650M OS LOCKED UP (quite possibly more). Given basic laws of supply and demand, what effect do we expect when names, locations, and $ amounts for contracted physicians are officially released soon?
This is one of the biggest no-brainers EVER.
Feel free to join him—we’ll gladly take your money too!
This is exactly what was released the day before yesterday (on 6/19)—or am I missing the new content/substance here?
Parabola sighted!
Runaway train!!
Shorts: relent now or get crushed!
These fools keep fishing with some low AF bid—ain’t no bites!
Throw shorty from the train!
Hello, posse! CELZ AWAY!
LOCK EVERY SHARE—make life hard for shorts!
Put in a GTC sell for all shares at the highest dollar value allowable by your brokerage (mine are locked at $20).
Locked shares cannot be borrowed for use in manipulating the price of our equity downward.
CELZ in control!!!